Clinical Trial: The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Type 2 Diabetes Mellitus (T2DM)
Study Type: INTERVENTIONAL
Official Title: The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.
Brief Summary:
Diabetes mellitus is a progressive endocrine disease characterized by insulin deficiency with or without insulin resistance.Management of type 2 diabetes requires a comprehensive team following and monitoring the disease carefully.Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor, has been shown to be an effective medication for the treatment of T2DM, and has been demonstrated to improve glycemic control.The investigators believe that enrolling clinical pharmacist intervention as a part of a…
Read more